5/21/2024 3:30:26 PM FDA LDT Rule Begins Enforcement Discretion Phaseout, But Some Discretion Remains By Rebecca Jones McKnight Kevin Madagan Sarah Thompson Schick Akosua Tuffuor +1 more... Show less On May 14, 2024, FDA hosted a webinar to provide an overview of its final rule “Medical Devices; Laboratory Developed Tests” as well as...
10/18/2023 4:33:45 AM The Latest Episode of the LDT Drama: FDA Issues Long-Awaited Proposed Rule for Laboratory Developed Tests By Sarah Thompson Schick Rebecca Jones McKnight Matthew Loughran Kevin Madagan +1 more... Show less On October 31, FDA will be offering a webinar on its proposed rule ”Medical Devices; Laboratory Developed Tests.” This webinar comes...
6/9/2023 9:24:19 PM FDA Issues Draft Guidance on Good Clinical Practice in Ongoing Clinical Trial Modernization Efforts By Kevin Madagan Sarah Thompson Schick Note: This is Part 2 in a series of blog posts on developments from the U.S. Food and Drug Administration (“FDA”) regarding its...
4/21/2023 2:40:21 PM New Opportunities, New Challenges: FDA Elaborates on use of Digital Health in Drug and Biological Product Development By Sarah Thompson Schick Rebecca Jones McKnight Vicki Tankle Roswill Mejia +1 more... Show less Note: This is Part 1 in a series of blog posts on developments from the U.S. Food and Drug Administration (“FDA”) regarding its...
10/14/2021 1:24:04 PM FDA codifies requirements for the medical device De Novo classification process By Andrew Lu On October 5, 2021, the U.S. Food and Drug Administration (“FDA”) published a final rule to establish requirements for the medical device...
8/26/2021 12:30:14 PM FDA clarifies evidence and knowledge requirements in intended use final rule By Kevin Madagan Sung Park John Kendzior On August 2, 2021, the U.S. Food and Drug Administration (“FDA”) published a final rule amending existing regulations (21 C.F.R. §...
12/1/2020 6:27:34 PM Marketers Beware: As COVID-19 cases increase, FDA, FTC increase efforts to crack down on fraudulent and deceptive marketing and sales of purported ‘Virus Cures’ By Kevin Madagan Alison Peters The Food and Drug Administration (“FDA”) and the Federal Trade Commission (“FTC”) have been fighting fraudulent and deceptive advertising...
11/6/2020 8:08:45 PM CMS finalizes rule to ensure no-cost COVID-19 vaccine By David Hartmann On October 28, 2020, the Centers for Medicare & Medicaid Services (CMS) issued an interim final rule with comment period (IFR) in an...
9/16/2020 4:28:08 PM FDA issues draft guidance regarding principles for selecting, developing, modifying, & adapting patient-reported outcome instruments for use in medical device evaluation By John Kendzior Ryan Pate On August 31, 2020, the Food and Drug Administration (FDA) issued draft guidance regarding principles for selecting, developing,...
6/19/2020 5:28:54 PM FDA issued guidance on statistical considerations for clinical trials during the COVID-19 public health emergency By John Kendzior Ryan Pate On June 17, the Food and Drug Administration (FDA) continued its efforts to mitigate COVID-19’s disrupting impact on clinical trials by...